Adaptimmune Therapeutics total equity 2019 to 2023
Compared to the earliest depicted value from 2019 this is a total decrease by approximately 91.11 million U.S. dollars. The trend from 2019 to 2023 shows ,however, that this decrease did not happen continuously.